Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GLI3 | hg38_v1_chr7_-_42237059_42237183 | 0.52 | 2.2e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_85668172 Show fit | 6.91 |
ENST00000428225.5
ENST00000519937.7 |
surfactant protein B |
|
chr15_+_81299416 Show fit | 4.23 |
ENST00000558332.3
|
interleukin 16 |
|
chr14_-_106557465 Show fit | 3.39 |
ENST00000390625.3
|
immunoglobulin heavy variable 3-49 |
|
chr2_-_136118142 Show fit | 3.38 |
ENST00000241393.4
|
C-X-C motif chemokine receptor 4 |
|
chr14_-_106335613 Show fit | 3.28 |
ENST00000603660.1
|
immunoglobulin heavy variable 3-30 |
|
chr22_+_22409755 Show fit | 3.28 |
ENST00000390299.2
|
immunoglobulin lambda variable 1-40 |
|
chr14_-_106627685 Show fit | 3.11 |
ENST00000390629.3
|
immunoglobulin heavy variable 4-59 |
|
chr19_+_44914588 Show fit | 3.02 |
ENST00000592535.6
|
apolipoprotein C1 |
|
chr19_+_18173148 Show fit | 3.00 |
ENST00000597802.2
|
IFI30 lysosomal thiol reductase |
|
chr3_+_32951636 Show fit | 2.99 |
ENST00000330953.6
|
C-C motif chemokine receptor 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 36.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
2.7 | 10.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.0 | 8.8 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 7.7 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 5.8 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.7 | 5.6 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.0 | 5.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
1.1 | 5.3 | GO:0032796 | uropod organization(GO:0032796) |
0.1 | 5.2 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.2 | 5.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 16.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.4 | 11.1 | GO:0042627 | chylomicron(GO:0042627) |
0.7 | 9.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 7.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 7.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 7.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 6.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.2 | 6.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 5.6 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 5.2 | GO:0000922 | spindle pole(GO:0000922) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 29.0 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 17.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.0 | 11.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 10.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 6.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.7 | 5.6 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.0 | 5.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 5.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 4.4 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.2 | 4.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 10.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 10.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 9.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 8.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 5.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 4.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 4.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 4.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 3.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 3.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 18.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 8.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 5.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 5.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 4.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 4.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 4.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 3.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 3.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 3.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |